Pyxis Historical Income Statement
| PYXS Stock | USD 2.01 0.18 9.84% |
Historical analysis of Pyxis Oncology income statement accounts such as Selling General Administrative of 20.7 M, Total Revenue of 0.0, Other Operating Expenses of 64.1 M or Research Development of 43.3 M can show how well Pyxis Oncology performed in making a profits. Evaluating Pyxis Oncology income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Pyxis Oncology's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Pyxis Oncology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pyxis Oncology is a good buy for the upcoming year.
Pyxis |
About Pyxis Income Statement Analysis
Pyxis Oncology Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Pyxis Oncology shareholders. The income statement also shows Pyxis investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Pyxis Oncology Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Pyxis Oncology. It is also known as Pyxis Oncology overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Pyxis Oncology's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Pyxis Oncology current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pyxis Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Pyxis Stock please use our How to Invest in Pyxis Oncology guide.At this time, Pyxis Oncology's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 7.3 M in 2024, whereas Selling General Administrative is likely to drop slightly above 20.7 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 23K | 2.8M | 6.9M | 7.3M | Net Interest Income | 23K | 2.8M | 6.9M | 7.3M |
Pyxis Oncology income statement Correlations
Click cells to compare fundamentals
Pyxis Oncology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pyxis Stock Analysis
When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.